Friday, Apr 26, 2024
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Science and Tech
Sport
Business
Rewind
...
NRI
View Point
cartoon
Columns
Education Today
Reviews
Property
Videos
Lifestyle
E-Paper
NRI
View Point
cartoon
Columns
Reviews
Education Today
Property
Videos
Lifestyle
"pharmaceuticals-company"
Dr Reddy’s enters into voluntary licensing agreement with Eli Lilly
To manufacture and commercialise baricitinib in India, approved for use in combination with remdesivir for the treatment of suspected or laboratory confirmed Covid-19 in hospitalised adults
Gland Pharma IPO to open on Nov 9
The price band of the offer has been fixed at Rs 1,490 to Rs 1,500 per Equity Share
Dr Reddy’s, RDIF receive approval to conduct clinical trial for Sputnik V vaccine
This will be a multi-centre and randomised controlled study, which will include safety and immunogenicity study, Dr Reddy’s said in a statement.
Latest News
Opinion: The new age ‘girmitiyas’
5 hours ago
Editorial: Playing with public health
5 hours ago
No respite from heatwave till May
6 hours ago
Fruit vendors under watch for violations
6 hours ago
Cong leaders create ruckus over Nama’s nomination
6 hours ago
Bar license of Urvashi Bar cancelled
6 hours ago
Youth Congress leaders complain against pro-BJP SM influencers
7 hours ago
LS Polls preparedness in Rachakonda
7 hours ago